title: Neuregulins as potential drugs for neurological disorders.
authors.affiliation: Cambridge NeuroScience, Inc., Massachusetts 01239, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Marchionni
authors.forename: C J
authors.initials: CJ
authors.lastname: Kirk
authors.forename: I J
authors.initials: IJ
authors.lastname: Isaacs
authors.forename: C J
authors.initials: CJ
authors.lastname: Hoban
authors.forename: N K
authors.initials: NK
authors.lastname: Mahanthappa
authors.forename: E S
authors.initials: ES
authors.lastname: Anton
authors.forename: C
authors.initials: C
authors.lastname: Chen
authors.forename: F
authors.initials: F
authors.lastname: Wason
authors.forename: D
authors.initials: D
authors.lastname: Lawson
authors.forename: F P
authors.initials: FP
authors.lastname: Hamers
authors.forename: P D
authors.initials: PD
authors.lastname: Canoll
authors.forename: R
authors.initials: R
authors.lastname: Reynolds
authors.forename: B
authors.initials: B
authors.lastname: Cannella
authors.forename: D
authors.initials: D
authors.lastname: Meun
authors.forename: W F
authors.initials: WF
authors.lastname: Holt
authors.forename: W D
authors.initials: WD
authors.lastname: Matthew
authors.forename: L E
authors.initials: LE
authors.lastname: Chen
authors.forename: W H
authors.initials: WH
authors.lastname: Gispen
authors.forename: C S
authors.initials: CS
authors.lastname: Raine
authors.forename: J L
authors.initials: JL
authors.lastname: Salzer
authors.forename: D I
authors.initials: DI
authors.lastname: Gwynne
mesh_terms: D000818:Animals; D006023:Glycoproteins / Q000502:physiology*; D006801:Humans; D009414:Nerve Growth Factors / Q000502:physiology*; D009420:Nervous System / Q000254:growth & development; D009422:Nervous System Diseases / Q000188:drug therapy*; D009424:Nervous System Physiological Phenomena; D020880:Neuregulins; D011994:Recombinant Proteins
chemical_list: D006023:Glycoproteins; D009414:Nerve Growth Factors; D020880:Neuregulins; D011994:Recombinant Proteins